CAD 1.22
(2.1%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 42.88 Million USD | -31.59% |
2022 | 84.6 Million USD | 15.21% |
2021 | 73.43 Million USD | 135.98% |
2020 | -204.1 Million USD | -22.61% |
2019 | -166.46 Million CAD | -342.93% |
2018 | -37.58 Million CAD | -171.39% |
2017 | -13.84 Million CAD | -8617.95% |
2016 | -158.85 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 7.54 Million USD | -40.32% |
2024 Q1 | 17.12 Million USD | -11.9% |
2023 Q3 | 20.4 Million USD | 314.53% |
2023 FY | 57.87 Million USD | -31.59% |
2023 Q2 | -9.51 Million USD | -142.77% |
2023 Q1 | 22.23 Million USD | 120.09% |
2023 Q4 | 19.02 Million USD | -6.77% |
2022 Q3 | -129.81 Million CAD | -14.48% |
2022 FY | 84.6 Million USD | 15.21% |
2022 Q4 | -110.69 Million CAD | 14.73% |
2022 Q2 | -113.39 Million CAD | -4.56% |
2022 Q1 | -108.44 Million CAD | -8.26% |
2021 FY | 73.43 Million USD | 135.98% |
2021 Q4 | -100.17 Million CAD | 28.07% |
2021 Q3 | -139.27 Million CAD | 0.0% |
2020 FY | -204.1 Million USD | -22.61% |
2019 FY | -166.46 Million CAD | -342.93% |
2018 FY | -37.58 Million CAD | -171.39% |
2017 FY | -13.84 Million CAD | -8617.95% |
2016 FY | -158.85 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aurora Cannabis Inc. | -46.45 Million CAD | 192.315% |
Avicanna Inc. | -7.93 Million CAD | 640.564% |
Avant Brands Inc. | -1.45 Million CAD | 3055.41% |
Cardiol Therapeutics Inc. | -29.78 Million CAD | 243.973% |
Crescita Therapeutics Inc. | -1.95 Million CAD | 2292.382% |
Knight Therapeutics Inc. | -2.89 Million CAD | 1583.841% |
MediPharm Labs Corp. | -18.25 Million CAD | 334.95% |
OrganiGram Holdings Inc. | -242.73 Million CAD | 117.666% |
Canopy Growth Corporation | -228.71 Million CAD | 118.75% |
Willow Biosciences Inc. | -13.18 Million CAD | 425.315% |
Auxly Cannabis Group Inc. | -19 Million CAD | 325.641% |